Zinc Finger Protein as Potential Drug Target Or Biomarker (G29066)

Target Name: ZC3H7A

NCBI ID: G29066

ZC3H7A

Zinc Finger Protein as Potential Drug Target Or Biomarker

Zinc Finger CCCH-Type Containing 7A (ZC3H7A) is a protein that has been identified as a potential drug target or biomarker. It is a zinc finger gene that is located on chromosome 16 and encodes a protein with a characteristic structure known as a zinc finger . Zinc fingers are a type of gene transcription factor that is characterized by the presence of a zinc finger gene that is conserved in the genomes of many different species.

The zinc finger gene is a transmembrane protein that is involved in various cellular processes. It has been shown to play a role in the regulation of gene expression, DNA replication, and cell signaling. In addition, zinc fingers have also been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of ZC3H7A is its structure. It consists of a domain that is similar to other zinc finger proteins, including a N-terminal zinc finger, a C-terminal zinc finger, and a unique N-terminal extension that is known as a \"Zinc Finger-like\" domain. This extension is thought to be involved in the interaction of ZC3H7A with other proteins.

In addition to its structural features, ZC3H7A has also been shown to have unique functions in various cellular processes. For example, it has been shown to play a role in the regulation of cell adhesion, a process that is important for the development and maintenance of tissues and organs. It has also been shown to be involved in the regulation of cell signaling, a process that is important for the regulation of cellular processes such as cell growth, differentiation, and survival.

In addition to its functions in cellular processes, ZC3H7A has also been shown to be a potential drug target. One reason for this is its unique structure, which allows it to interact with other proteins in a specific way. This can make it an attractive target for small molecules that can modulate its function. In addition, ZC3H7A has also been shown to be involved in the regulation of gene expression, which can make it an attractive target for drugs that target gene expression.

Another potential reason for the potential drug targeting of ZC3H7A is its involvement in the development and progression of various diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also has been shown to be involved in the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

In conclusion, Zinc Finger CCCH-Type Containing 7A (ZC3H7A) is a protein that has unique functions in cellular processes and is a potential drug target or biomarker. Its unique structure and functions make it an attractive target for small molecules that can modulate its function . Additionally, its involvement in the development and progression of various diseases makes it a potential biomarker for these conditions. Further research is needed to fully understand the role of ZC3H7A in cellular processes and its potential as a drug target.

Protein Name: Zinc Finger CCCH-type Containing 7A

Functions: May be a specific regulator of miRNA biogenesis. Binds to microRNAs MIR7-1, MIR16-2 and MIR29A hairpins recognizing the 3'-ATA(A/T)-5' motif in the apical loop

The "ZC3H7A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZC3H7A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets